Invention Grant
- Patent Title: Schisandrae fructus extracts for inhibition or prevention of H1N1 influenza virus infection and its application thereof
- Patent Title (中): 五味子提取物用于抑制或预防H1N1流感病毒感染及其应用
-
Application No.: US13298607Application Date: 2011-11-17
-
Publication No.: US08414938B2Publication Date: 2013-04-09
- Inventor: Wen-Liang Chang , Chen-Wen Yao , Chi-Hong Chu , An-Rong Lee , Ann Chen , Wen-Hsin Huang , Kuo-Yuan Hwa , Chiao-Ying Chien , Chien-Yi Pai
- Applicant: Wen-Liang Chang , Chen-Wen Yao , Chi-Hong Chu , An-Rong Lee , Ann Chen , Wen-Hsin Huang , Kuo-Yuan Hwa , Chiao-Ying Chien , Chien-Yi Pai
- Applicant Address: TW Taipei
- Assignee: National Defense Medical Center
- Current Assignee: National Defense Medical Center
- Current Assignee Address: TW Taipei
- Agency: WPAT, P.C.
- Agent Anthony King
- Priority: TW100102500A 20110124
- Main IPC: A01N65/00
- IPC: A01N65/00

Abstract:
Disclosed are an Schisandrae fructus extract for inhibition or prevention of influenza and its application, wherein the Schisandrae fructus extract is obtained by water, methanol, or ethanol extraction process and the extract comprises compounds such as schisandrone, benzoylgomisin P, wulignan A1, epigomisin O, epiwulignan A1, and tigloylgomisin P. The extracts and purified compounds of Schisandrae fructus has anti-influenza virus H1N1 and H1N1-TR (a Tamiflu drug resistant virus strain) activities, therefore the extracts and the purified compounds of Schisandrae fructus can be applied as an inhitibory agent of a pharmaceutical composition for treatment or prevention agent for influenza infection.
Public/Granted literature
Information query